Evidence map›Paper›PMID 30774682›Full record

ArticleIranian journal of pathology2018

Investigation of the

Amir Tajbakhsh, Faezeh Ghasemi, Seyedeh Zohre Mirbagheri, Mastoureh Momen Heravi, Mehdi Rezaee, Zahra Meshkat

Open access · greenAbstract read
In one paragraph

Article in Iranian journal of pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Epidemiological Profile andInternational journal of microbiology · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Detection of genomic mutations inNew microbes and new infections · 2021
    Article
  10. Mutational Frequencies in MycobacterialPakistan journal of medical sciences
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Amir TajbakhshDept. of New Sciences and Technologies, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Faezeh GhasemiDept. of Biotechnology, Faculty of Medicine, Arak University of Medical Sciences, Arak, Iran.
Seyedeh Zohre MirbagheriAntimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Mastoureh Momen HeraviAntimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Mehdi RezaeeStudent Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
Zahra MeshkatAntimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Mashhad University of Medical Sciences · IRArak University of Medical Sciences · IRYasouj University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesThe incidence of rifampin-resistant strains of

methodsIn this study, 88

resultsMutations in three codons of

conclusionAccording to the results of this study, the frequency of rifampin-resistant strains of

Indexed as

Multiplex PCRMycobacterium tuberculosisRifampin resistancerpoB gene

Identifiers

PMID30774682
PMCPMC6358560
OpenAlexW2900679370

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.